Irbesartan ameliorates diabetic kidney injury in <i>db/db</i> mice by restoring circadian rhythm and cell cycle

Abstract

Generally, irbesartan can effectively treat DKD by regulating the circadian rhythm and cell cycle. The DEGs and pathways identified in the study will provide new insights into the potential mechanisms of irbesartan in the treatment of DKD.